Clinical Trials in Georgia

Showing 7841-7860 of 14,426 trials

Gammagard Liquid and rHuPH20 in PID

NCT00814320

The purpose of the study is to develop a subcutaneous treatment option for participants with Primary Immunodeficiency Diseases (PID) that allows an administration of Immune Globulin Intravenous (Human), 10% at the same frequency as IV administration.

Primary Immunodeficiency Diseases (PID)

Baxalta now part of Shire89 participantsStarted Dec 2008

Cypress, California, United States • Irvine, California, United States • Los Angeles, California, United States +11 more locations

COMPLETEDPhase 165 miles

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

NCT02669017

This study evaluates ADCT-402 in participants with Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL). Participants will participate in a dose escalation phase (Part 1) and dose expansion (Part 2). In Part 2, participants will receive the dose level identified in Part 1.

Non-Hodgkin LymphomaBurkitt's LymphomaChronic Lymphocytic Leukemia+6 more

ADC Therapeutics S.A.183 participantsStarted Mar 2016

La Jolla, California, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States +8 more locations

Gammagard Liquid and rHuPH20 in PID

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

Find Trials by Condition in Georgia

Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)

A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy

Tanezumab In Osteoarthritis Of The Hip Or Knee

TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis

Open Label Extension Study of PREOS

Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial

Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)

A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)

A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection

Evaluation of Efficacy and Safety of SDN-037

GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1)

Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis

Partial Breast Irradiation Using Non Invasive Approach for Early Stage Breast Cancer

A Renal Impairment Study for PF-06651600

Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)